CL2018001873A1 - Anticuerpos igy para la prevención de infestación e infección de liendres marinas - Google Patents

Anticuerpos igy para la prevención de infestación e infección de liendres marinas

Info

Publication number
CL2018001873A1
CL2018001873A1 CL2018001873A CL2018001873A CL2018001873A1 CL 2018001873 A1 CL2018001873 A1 CL 2018001873A1 CL 2018001873 A CL2018001873 A CL 2018001873A CL 2018001873 A CL2018001873 A CL 2018001873A CL 2018001873 A1 CL2018001873 A1 CL 2018001873A1
Authority
CL
Chile
Prior art keywords
infestation
prevention
infection
nits
sea
Prior art date
Application number
CL2018001873A
Other languages
English (en)
Inventor
Jan Ove Morlandstø
Øystein Evensen
Per Olav Skjervold
Original Assignee
Norifish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norifish As filed Critical Norifish As
Publication of CL2018001873A1 publication Critical patent/CL2018001873A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Biotechnology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Pest Control & Pesticides (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UNA COMPOSICIÓN IGY OBTENIDA POR MEDIO DE INMUNIZACIÓN CON UN CALIGIDAE, Y USO DE ESTA COMPOSICIÓN IGY EN LA REDUCCIÓN DE INFESTACIÓN Y/O PREVENCIÓN Y/O TRATAMIENTO DE INFECCIÓN DE UN SALMÓNIDO CON UN PARÁSITO DEL ORDEN CALIGIDAE ES DESCRITO.
CL2018001873A 2016-01-22 2018-07-10 Anticuerpos igy para la prevención de infestación e infección de liendres marinas CL2018001873A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20160113A NO345611B1 (en) 2016-01-22 2016-01-22 IgY antibody composition, and use of the composition for reduction of infestation and infection by a Caligidae

Publications (1)

Publication Number Publication Date
CL2018001873A1 true CL2018001873A1 (es) 2019-01-25

Family

ID=58737839

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2018001875A CL2018001875A1 (es) 2016-01-22 2018-07-10 Anticuerpos igy para la prevención de infestación e infección de piojos de mar
CL2018001873A CL2018001873A1 (es) 2016-01-22 2018-07-10 Anticuerpos igy para la prevención de infestación e infección de liendres marinas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2018001875A CL2018001875A1 (es) 2016-01-22 2018-07-10 Anticuerpos igy para la prevención de infestación e infección de piojos de mar

Country Status (6)

Country Link
EP (3) EP3405487B1 (es)
CA (2) CA3009349C (es)
CL (2) CL2018001875A1 (es)
DK (3) DK180987B1 (es)
NO (1) NO345611B1 (es)
WO (2) WO2017126977A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3919073B1 (en) * 2020-06-05 2024-05-15 Schweitzer Biotech Company Ltd. Composition for preventing infestation and infection of sea lice on salmon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007001736A1 (es) * 2006-06-14 2008-03-24 Verenium Corp Polinucleotido aislado que codifica una tripsina de lepeophtherius salmonis y al menos un epitopo de celula t promiscuo; polipeptido codificado; composiciones que comprenden dichos polinucleotido y polipeptido; y metodo de modulacion de una respuesta
ES2445467B1 (es) * 2012-08-01 2014-12-12 Consejo Superior De Investigaciones Científicas (Csic) Vacuna frente a infestaciones provocadas por artrópodos hematófagos

Also Published As

Publication number Publication date
DK201870440A1 (en) 2018-09-11
CA3009344A1 (en) 2017-07-27
EP3405487B1 (en) 2021-03-10
EP3405487A1 (en) 2018-11-28
DK180291B1 (en) 2020-10-08
DK202070286A8 (en) 2021-07-08
EP3741776A1 (en) 2020-11-25
DK201870441A1 (en) 2018-09-11
CA3009349A1 (en) 2017-07-27
DK180987B1 (en) 2022-09-05
EP3405488A1 (en) 2018-11-28
CL2018001875A1 (es) 2019-01-25
CA3009349C (en) 2023-01-24
DK202070286A1 (en) 2020-05-18
NO345611B1 (en) 2021-05-10
NO20160113A1 (en) 2017-07-24
WO2017126976A1 (en) 2017-07-27
WO2017126977A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
CL2021000149A1 (es) Composiciones anti-cd112r y métodos
CL2017000285A1 (es) Terapia combinada para el tratamiento de un paramixovirus
DOP2019000180A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
CL2018002878A1 (es) Composiciones y anticuerpos anti-tim-3.
CL2018000744A1 (es) Anticuerpos anti-tigit (inmunoreceptor de linfocitos t con dominios ig e itim) y metodos de uso.
ECSP19086810A (es) Anticuerpos que se unen específicamente a pd-1 y métodos de uso
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
BR112017007170A2 (pt) anticorpos anti-ox40 humanizados e suas utilizações
CU20160187A7 (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13, 13a-octahidro-2,5-metanopirido[1',2':4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
BR112019005908A2 (pt) uso de combinação de anticorpo anti-pd-1 e inibidor de vegfr na preparação de fármaco para tratamento de cânceres
CL2021000608A1 (es) Vacunas neumocócicas multivalentes
CL2020001391A1 (es) Formulación liofilizada de un anticuerpo monoclonal contra la transtirretina.
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
CR20190271A (es) Anticuerpos antitau y métodos de uso
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
EA201790545A1 (ru) Антитела и иммуноконъюгаты против her2
UY37336A (es) Anticuerpos anti-virus del zika y métodos de uso
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
CL2019003799A1 (es) Anticuerpos de unión a il–1beta para el uso en el tratamiento del cáncer.
CR20180141A (es) Anticuerpos anti-cd 19 humano humanizados y métodos de utilización
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
CL2017002596A1 (es) Neutralización del virus chikungunya mediada por anticuerpos
AR108468A1 (es) POLIPÉPTIDOS DE FUSIÓN CD40L-Fc Y MÉTODOS DE USO DE LOS MISMOS
CO2020015923A2 (es) Antagonista de gremlin-1 para la prevención y tratamiento del cáncer
BR112019013468A8 (pt) Anticorpos anti-hiv-1 amplamente neutralizante e métodos de uso dos mesmos